• About us
    • Profile
    • Board of Directors
    • Scientific Directors
  • Our Science
    • Strategy
    • Activities and Technologies
  • Pipeline
    • Pipeline
    • OncoFAP-Radio Conjugate
    • OncoFAP-Drug Conjugate
    • Onco IX (PHC-102, Imaging)
  • Press releases & Events
  • Work with us
    • Careers
    • Industrial Ph.D. Program
    • Partnering
  • About us
    • Profile
    • Board of Directors
    • Scientific Directors
  • Our Science
    • Strategy
    • Activities and Technologies
  • Pipeline
    • Pipeline
    • Onco IX (PHC-102, Imaging)
    • OncoFAP-Radio Conjugate
    • OncoFAP-Drug Conjugate
  • Press releases & Events
  • Work with us
    • Careers
    • Industrial Ph.D. Program
    • Partnering

Philochem announces a publication entitled: “DNA-Compatible Diazo-Transfer Reaction in Aqueous Media Suitable for DNA-Encoded Chemical Library Synthesis”

by last | Nov 20, 2019 | 2019, Press Releases

Link to Paper

Philochem will be attending the 9th International symposium on DNA-Encoded Chemical Libraries in Zurich (Switzerland) from September 5 to 6, 2019

by last | Aug 1, 2019 | 2019, Press Releases

Philochem will be attending the 9th International symposium on DNA-Encoded Chemical Libraries in Zurich (Switzerland) from September 5 to 6, 2019 9th International symposium on DNA-Encoded Chemical Libraries Dr. Florent Samain will give a presentation on “Encoded...

Philogen announces capital increase

by last | May 13, 2019 | 2019, Press Releases

Philogen announces capital increase

Philochem will be attending the 20th Annual Drug Discovery Summit in Berlin

by last | May 1, 2019 | 2019, Press Releases

Philochem will be attending the 20th Annual Drug Discovery Summit in Berlin (Germany) from June 11 to 12, 2019. 20th Annual Drug Discovery Summit Dr. Florent Samain will give a presentation on: “Encoded Self-Assembling Chemical (ESAC)...

Philochem will be attending the ACS Spring meeting: Chemistry for new Frontiers in Orlando

by last | Mar 1, 2019 | 2019, Press Releases

Philochem will be attending the ACS Spring meeting: Chemistry for new Frontiers in Orlando (United States) from March 31 to April 4, 2019 ACS Spring Dr. Florent Samain, Dr. Etienne Donckele and Martina Bigatti will present posters

Philogen announces through its wholly-owned Swiss subsidiary, Philochem AG, a participation in the Eurostars Cut-off 8 Project (ComPAIR): “Comprehensive Prediction of Allogeneic Immune Response”

by last | Mar 1, 2019 | 2019, Press Releases

Philogen announces through its wholly-owned Swiss subsidiary, Philochem AG, a participation in the Eurostars Cut-off 8 Project (ComPAIR): “Comprehensive Prediction of Allogeneic Immune Response” ComPAIR
« Older Entries

Recent Posts

  • Philogen to attend the TIDES Europe 2022 in Vienna, Austria (16-18 November)
  • Philogen to attend the Society for Immunotherapy of Cancer’s 37th Annual Meeting 2022 in Boston (8-12 November 2022)
  • Philochem will be attending the 10th World ADC Conference in London
  • Philogen announces the publication of a new study in the European Journal of Nuclear Medicine and Molecular Imaging
  • Philogen announces publication in Chem (Cell Press) on novel affinity matured OncoFAP ligands

Recent Comments

    Philochem AG ©

    Privacy / Contacts

    • Follow

    Philochem AG | Libernstrasse 3 | CH-8112 | Otelfingen – Switzerand |MWST-Nr/VAT-REG: CHE-113.181.443 | Registration Nr. CH-020.3.030.226-7 Ph. (+41) 43 544 88 00 | Fax (+41) 43 544 88 09| info@philochem.ch